Effects of BG9928, an adenosine A1 receptor antagonist, in patients with congestive heart failure

Journal of Clinical Pharmacology

Volumn 51, Issue 6, 2011, Pages 899-907

  Gottlieb, Stephen S ^a   Ticho, Barry ^b   Deykin, Aaron ^b   Abraham, William T ^c   Denofrio, David ^d   Russell, Stuart D ^e   Chapman, Douglas ^f   Smith, William ^g   Goldman, Steven ^h   Thomas, Ignatius ⁱ  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BIOGEN   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

^g UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ Medical Research Institute   (United States)

Author keywords

adenosine; BG9928; diuresis; heart failure; sodium

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; SODIUM; TONAPOFYLLINE;

ADULT; APPLICATION SITE PAIN; AREA UNDER THE CURVE; ARTICLE; ASTHENIA; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CONTUSION; COUGHING; CREATININE CLEARANCE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG FATALITY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG URINE LEVEL; DYSPNEA; EPILEPTIC STATE; FEMALE; HEART ARREST; HEART HEMODYNAMICS; HUMAN; INDUCED HYPOTENSION; KIDNEY FUNCTION; MALE; MAXIMUM PLASMA CONCENTRATION; MULTICENTER STUDY; NECK PAIN; PHARMACOLOGICAL PARAMETERS; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SODIUM EXCRETION; SODIUM URINE LEVEL; TACHYCARDIA; THORAX PAIN; TIME TO MAXIMUM PLASMA CONCENTRATION; WEIGHT REDUCTION;

ADENOSINE A1 RECEPTOR ANTAGONISTS; BODY WEIGHT; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; SODIUM; STATUS EPILEPTICUS; XANTHINES;

EID: 79955792526     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010375957     Document Type: Article

References (21)

1. Cody RJ, Kubo SH, Pickworth KK. Diuretic treatment for the sodium retention of congestive heart failure. Arch Intern Med. 1994 ; 154: 1905-1914 (Pubitemid 24276374)
2. Gottlieb SS, Skettino SL, Wolff A, et al. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol. 2000 ; 35: 56-59 (Pubitemid 30061259)
3. Maxwell AP, Ong HY, Nicholls DP. Influence of progressive renal dysfunction in chronic heart failure. Eur J Heart Fail. 2002 ; 4: 125-130 (Pubitemid 34233497)
4. Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002 ; 8: 136-141 (Pubitemid 34857278)
5. Krumholz HM, Chen YT, Vaccarino V, et al. Correlates and impact on outcomes of worsening renal function in patients ?65 years of age with heart failure. J Am Coll Cardiol. 2000 ; 85: 1110-1113 (Pubitemid 30214258)
6. Mosterd A, Cost B, Hoes AW, et al. The prognosis of heart failure in the general population: the Rotterdam Study. Eur Heart J. 2001 ; 22: 1318-1327 (Pubitemid 32737624)
7. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004 ; 147: 331-338 (Pubitemid 38176835)
8. Edlund A, Ohlsen H, Sollevi A. Renal effects of local infusion of adenosine in man. Clin Sci (Lond). 1994 ; 87: 143-149 (Pubitemid 24267081)
9. Marraccini P, Fedele S, Marzilli M, et al. Adenosine-induced renal vasoconstriction in man. Cardiovasc Res. 1996 ; 32: 949-953 (Pubitemid 26342660)
10. Munger KA, Jackson EK. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system. Am J Physiol. 1994 ; 267: F783 - F790
11. Metra M, Massie BM, O'Connor CM. Effects of rolofylline in patients with acute heart failure syndrome and renal impairment: Findings from the placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function (PROTECT) study. Eur Heart J. 2009 ; 30 :
12. Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC. The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol. 2007 ; 50: 1551-1560 (Pubitemid 47532320)
13. Gottlieb SS, Brater DC, Thomas I, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002 ; 105: 1348-1353 (Pubitemid 34260427)
14. Greenberg B, Thomas I, Banish D, et al. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol. 2007 ; 50: 600-606 (Pubitemid 47198998)
15. Cotter G, Dittrich HC, Weatherley BD, et al. PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail. 2008 ; 14: 631-640
16. Weinfeld MS, Chertow GM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J. 1999 ; 138: 285-290 (Pubitemid 29379679)
17. Wang DJ, Dowling TC, Meadows D, et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation. 2004 ; 110: 1620-1625 (Pubitemid 39297985)
18. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005 ; 111: 1487-1491 (Pubitemid 40470642)
19. Cuffe MS, Califf RM, Adams KF, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002 ; 287: 1541-1547 (Pubitemid 34269999)
20. Kalk P, Eggert B, Relle K, et al. The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure. Br J Pharmacol. 2007 ; 151: 1025-1032 (Pubitemid 47195534)
21. Avsar E, Empson RM. Adenosine acting via A1 receptors, controls the transition to status epilepticus-like behaviour in an in vitro model of epilepsy. Neuropharmacology. 2004 ; 47: 427-437 (Pubitemid 38953234)